ISSN 1678-7757 printed version
ISSN 1678-7765 online version


Updated: 08/09/2016


Scope and policy


The Journal of Applied Oral Science is committed in publishing the scientific and technologic advances achieved by the dental and speech-language pathology and audiology communities, according to the quality indicators and peer reviewed material, with the objective of assuring its acceptability at the local, regional, national and international levels. The primary goal of The Journal of Applied Oral Science is to publish the outcomes of original investigations as well as invited case reports and invited reviews in the field of Oral Sciences, with emphasis in dentistry, speech-language pathology and audiology, and related areas.

This Journal adopts Creative Commons license CC-BY:

"This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials."

There is no fee to authors for submitting to the JAOS nor Article Processing Charge (APC).

2 General Guidelines

2.1 The papers sent for publication must be original and the simultaneous submission to other journal, either national or international, is not allowed. The Journal of Applied Oral Science shall retain the copyright of all papers published, including translations, yet allowing future reproduction as a transcription, provided the source is properly mentioned.

2.2 Only papers written in the English language shall be accepted, and the authors are fully responsible for the texts, citations and references.

2.3 The Journal of Applied Oral Science has the right to submit all manuscripts to the Editorial Board, which is fully authorized to settle the convenience of their acceptance, or return them to the authors with suggestions for modifications in the text and/or for adaptation to the editorial rules of the Journal. In this case, the manuscript will be re-evaluated by the Editor-in-Chief and Editorial Board.

2.4 The Journal of Applied Oral Science will receive literature reviews and case reports only upon invitation by the Editor.

2.5 The concepts stated on the papers published are full responsibility of the authors and do not necessarily reflect the opinion of the Editor-in-Chief and Editorial Board.

2.6 The dates of receipt of the original paper and its acceptance will be indicated in the occasion it is published.

2.7 Each corresponding author will receive one copy of the Journal. Additional reprints may be supplied upon request and must be paid by the authors.

2.8 Depending on the financial resources of the Journal of Applied Oral Science or the authors, color illustrations will be published at the discretion of the Editor-in-Chief.

3 Revision Criteria

3.1 Technical review: manuscripts will be firstly evaluated regarding presentation according to the instructions for authors and presence of mandatory documents required for submission. Manuscripts not in accordance with instructions will be returned to authors for adjustments before being reviewed by Associate Editors and referees.

3.2 Pre-evaluation: manuscripts in accordance with the instructions will be appreciated by Associate Editors regarding its adequacy to Journal scope and the presentation of all required documents. Papers considerated inadequate will be rejected and returned to authors.

3.3 Merit and content evaluation: papers approved by Associate Editors will be evaluated in their scientific merit and methods by at least two ad hoc referees from different institutions of that of the authors, besides the Editor-in-Chief. Editor-in-Chief will decide on manuscript acceptance. When revision of the original is required, the manuscript will be returned to the corresponding author for modification. A revised version with modifications will be re-submitted by the authors, and that will be re-evaluated by the Editor-in-Chief and Editorial Board, if necessary.

3.4 After approval of the scientific merit, manuscripts will pass through a final review performed by a professional assigned by the JAOS. The costs of this service will be under the authors’ responsibility, and instructions regarding the necessary procedures, the value of the service and the payment directly to the professional will be forwarded to the corresponding author. If manuscripts are still considered inadequate, they will be returned to authors for revision.

3.5 Authors and referees will be kept anonymous during the review process.

3.6 Contents of the manuscript are the authors’ responsibility and do not reflect the opinion of the Editor-in-Chief or Editorial Board.

4 Galley Proofs

4.1 Galley proofs will be sent to the corresponding author by electronic mail in pdf format for final approval.

4.2 Approval of galley proofs by the corresponding author should be returned with corrections, if necessary, within 72 hours.

4.3 If not returned within 72 hours, the Editor-in-Chief will consider the present version the final, and will not allow further modifications. Corrections in the galley proofs should be restricted to minor mistakes that do not modify the content of the manuscript. Major corrections will imply that the manuscript should enter the review process again.

4.4 Inclusion of new authors is not allowed at this phase of the publication process.


Form and preparation of manuscripts

1 Presentation of the Manuscript

1.1 Structure of the manuscript

Cover page (must be submitted as a supplementary file through the online submission system) which should contain only:

  • Title of the manuscript in English.
  • Names of the authors in direct order with their respective degrees and affiliations in English.
  • Full address of the corresponding author, to whom all correspondence should be addressed, including fax and phone number as well as e-mail address.

1.2 Text

  • The paper must be previously translated or reviewed by professional or company responsible for English language. The costs of this service will be under the authors’ responsibility. Authors with English as native language must submit as supplementary file a signed letter taking responsibility for the quality of the English language and editing of the text.
  • Title of the manuscript and subtitle, if necessary, in English.
  • Abstract: should comprise at most 300 words, highlighting a little introduction, objective, material and methods, results and conclusions.
  • Key words: (words or expressions that identify the contents of the manuscript). The authors are referred to the list of subjects of the "lndex Medicus" and DeCS (Health Sciences Descriptors available at Authors must use periods to separate the key words, which must have the first letter of the first word in capital letters. Ex: Dental implants. Fixed prosthesis. Photoelasticity. Passive fit.
  • Introduction: summary of the rationale and proposal of the study including only proper references. It should clearly state the hypothesis of the study.
  • Material and Methods: the material and the methods are presented with enough detail to allow confirmation of the findings. Include city, state and country of all manufacturers right after the first appearance of the products, reagents or equipments. Published methods should be referred to and briefly discussed, except if modifications were made. Indicate the statistical methods employed, if applicable. Please refer to item 3 for ethical principals and registration of clinical trials.
  • Results: presents the outcomes in a logical sequence in the text, tables and illustrations. Data contained in tables and illustrations should not be repeated in the text, and only important findings should be highlighted.
  • Discussion: this should emphasize the new and important aspects of the study and the resulting conclusions. Any data or information mentioned in the introduction or results should not be repeated. Findings of other important studies should be reported. The authors should point out the implications of their findings as well as their limitations.
  • Conclusion(s) (if any).
  • Acknowledgments (when appropriate). Acknowledge those who have contributed to the work. Specify sponsors, grants, scholarships and fellowships with respective names and identification numbers.
  • References (please refer to item 2.3)


The manuscript should be typed as follows: 1.5 spacing in 11 pt Arial font, with 3-cm margins at each side, on an A4 page, adding up to at most 15 pages, including the illustrations (graphs, photographs, tables, etc). The authors should keep a copy of the manuscript for possible requests.

2.1 Illustrations and Tables

2.1.1 The illustrations (photographs, graphs, drawings, charts, etc.), regarded as figures, should be limited to the least amount possible and should be uploaded in separate files, consecutively numbered with Arabic numbers according to the order they appear in the text.

2.1.2 Photographs should be sent in original colors and digitized in .jpg or tif formats with at least 10 cm width and at least 300 dpi. These illustrations should be provided in supplementary files and not inserted in the Word document.

2.1.3 The corresponding legends for figures should be clear, concise and typed at the end of the manuscript as a separate list preceded by the corresponding number.

2.1.4 The tables should be logically arranged, consecutively numbered with Arabic numbers. The legend shall be placed on the top of the tables. Tables should be open in the right and left laterals.

2.1.5 Footnotes should be indicated by asterisks and restricted to the least amount possible.

2.2 Citation of the Authors

Citation of the authors in the text may be performed in two manners:

1) Just numeric: " and interfere with the bacterial system and tissue system 3,4,7-10". References must be cited in a numeric ascending order within the paragraph.
2) or alphanumeric

  • one author - Silva23 (1986)
  • two authors - Silva and Carvalho25 (1987)
  • three authors - Ferreira, Silva and Martins27 (1987)
  • more than three authors- Silva, et al.28 (1988)
  • Punctuation characters such as periods and commas must be placed after the numeric citation of the authors. Ex: Ferreira38.

2.3 References

The references must follow the "Uniform requirements for manuscripts submitted to Biomedical Journals - Vancouver" available at:

2.3.1 All references must be cited in the text. They should be alphabetically ordered by the last name of the author and numbered in increasing order accordingly. The order of citation in the text should follow these numbers. Abbreviations of the titles of the international journals cited should follow the Index Medicus/MEDLINE.

2.3.2 Personal communications and unpublished data with no publication date must not be included in the reference list.

2.3.3 Abstracts, monographs, dissertations and theses will not be accepted as references.

2.3.4 The names of all authors should be cited up to 6 authors; in case there are more authors, the 6 first authors should be cited, followed by the expression ", et al.", which must be followed by "period" and should not be written in italics. Ex: Uhl, et al.

2.3.5 At most 30 references may be cited, except for invited reviews by the Editor-in-Chief.

Examples of references:


Melberg JR, Ripa LW, Leske GS. Fluoride in preventive dentistry: theory and clinical applications. Chicago: Quintessence; 1983.

Book chapter

Verbeeck RMH. Minerals in human enamel and dentin. ln: Driessens FCM, Woltgens JHM, editors. Tooth development and caries. Boca Raton : CRC Press; 1986. p.95-152.

Papers published in journals

Wenzel A, Fejerskov O. Validity of diagnosis of questionable caries lesions in occlusal surfaces of extracted third molars. Caries Res. 1992;26:188-93.

Papers with more than 6 authors

The first 6 authors are cited, followed by the expression ", et al."

Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E, et al. Childhood - leukemia in Europe after Chernobyl : 5 years follow-up. Br J Cancer. 1996;73:1006-12.

Papers without authors’ names

Seeing nature through the lens of gender. Science. 1993;260:428-9.

Volume with supplement and/or Special Issue

Davisdson CL. Advances in glass-ionomer cements. J Appl Oral Sci. 2006;14(sp. Issue):3-9.

Entire issue

Dental Update. Guildford 1991;18(1).

The authors are fully responsible for the correctness of the references.


3.1 Experimental procedures in humans and animals

The Journal of Applied Oral Science reassures the principles incorporated in the Helsinky Declaration and insists that all research involving human beings, in the event of publication in this journal, be conducted in conformity with such principles and others specified in the respective ethics committees of authors’ institution. In the case of experiments with animals, such ethical principles must also be followed. When surgical procedures in animals were used, the authors should present, in the Material and Methods section, evidence that the dose of a proper substance was adequate to produce anesthesia during the entire surgical procedure. All experiments conducted in human or animals must accompany a description, in the Material and Methods section, that the study was approved by the respective Ethics Committee of authors’ affiliation and provide the number of the protocol approval.

3.1.1 Papers presenting clinical trials or clinical studies in human volunteers or in animals must contain the Ethical Committee approval of the reports of the results presented for publication as mandatory supplementary file.

3.2 Clinical Trial Registration - International Standard Randomized Controlled Trial Number (ISRCTN)

The Journal of Applied Oral Science supports the policies of the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE) for the registration of clinical trials. The journal recognizes the importance of such initiatives for the registration and international publication of clinical studies with an open access. Therefore, the Journal of Applied Oral Science will publish only those clinical trials that have previously received an identification number, the ISRCTN, validated by the criteria established by the WHO and ICMJE. The WHO defines clinical trials as "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc".

3.2.1 Manuscripts presenting clinical trials in human volunteers must be submitted with the following mandatory supplementary files:

3.3 The Editor-in-Chief and the Editorial Board reserve the right to refuse manuscripts that show no clear evidence that the methods used were not appropriate for experiments in humans or animals.



Sending of manuscripts


1.1 Articles must be submitted through the following address

1.2 The original file containing the main manuscript must be submitted without the authors’ identification and affiliations. The cover page must be submitted as a supplementary file containing the names of the authors, affiliations and correspondence address.

1.3 Figures must be submitted as supplementary files according to the specifications of item 2.1 regarding the form and preparation of manuscripts.

1.4 - Tables must be prepared in Excel format and must be submitted as a supplementary files.

1.5 Files such as registration number of clinical trial or Ethics Committee approval must be sent as mandatory supplementary files.

1.6 The letter from the author responsible for English language or from a professional or company responsible for translation or review must be submitted as mandatory supplementary file.

1.7 The submission form, signed by ALL the authors, must be submitted as a supplementary file containing the following text:

By signing the Submission Form, the authors state:

Copyright transfer: In the event of publication of the above mentioned manuscript, we, the authors, agree with the use of Creative Commons license CC-BY and transfer to the Journal of Applied Oral Science all rights and interest of the manuscript. This document applies to translations and any preliminary presentation of the contents of the manuscript that has been accepted, but yet not published. If any authorship modification occurs after submission, a document with of agreement of all authors is required to be kept by the Editor-in-Chief. Exclusion of authors may only be accepted by his/her own request.

Responsibilities of the authors:

I hereby state that:

The content is original and does not consist of plagiarism or fraud;

The work is not under consideration or will be submitted to other journal until a final decision is issued by this journal;

I have effectively contributed to this work and am familiar with its contents;

I have read the final version and assume the responsibility for its contents. I understand that if the work, or part of it, is considered deficient or a fraud, I take shared responsibility with the other authors.

Release of conflict of interest:

All my affiliations, corporate or institutional, and all sources of financial support to this research are properly acknowledged, except when mentioned in a separate letter. I certify that do not have any commercial or associate interest that represents a conflict of interest in connection with the submitted manuscript.
PRINT NAME:_____________ SIGNATURE:__________ DATE:_____


[Home] [About this journal] [Editorial Board] [Subscription]

Creative Commons License All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License


Serviço de Biblioteca e Documentação FO-USP
Al. Dr. Octávio Pinheiro Brisolla 9-75
17012-901 Bauru SP Brasil
Tel.: +55 14 32358373